10 stories tagged glp-1, newest first.
49 points by hnburnsy | 26 comments
News article reporting that Novo Nordisk and Eli Lilly presented data at the ARDD conference suggesting GLP-1 drugs may slow biological aging.
136 points by dzink | 121 comments
University of California news article reporting a UC San Diego study suggesting a popular GLP-1 weight loss drug may slow biological aging.
44 points by gumby | 32 comments
Gizmodo article reporting on two studies finding GLP-1 drug users like Ozempic patients are more likely to experience hair loss and nail problems.
469 points by randycupertino | 370 comments
A Wiley Alzheimer's & Dementia journal article on semaglutide's association with lower predicted dementia risk; the capture shows a Cloudflare verification page.
411 points by giuliomagnifico | 748 comments
Cornell Chronicle article on research finding that GLP-1 drugs like Ozempic and Wegovy are associated with reductions in Americans' grocery and food purchases.
394 points by alexslobodnik | 481 comments
A GLP-1 Digest Substack post by Ashwin Sharma, MD arguing that GLP-1 drugs make applicants look healthy at underwriting while their risk later returns, disrupting life insurance.
365 points by pseudolus | 313 comments
Medical Xpress news article on a Stanford study finding a naturally occurring molecule that rivals Ozempic for weight loss without its side effects.
336 points by herbertl | 451 comments
A Substack essay by Todd Gagne arguing that GLP-1 weight-loss drugs could be a massive economic disruptor affecting jobs, investments, and industries.
322 points by Eumenes | 361 comments
University of Alberta Folio article on research finding a weight-loss drug shrinks heart muscle in mice and human cells.
377 points by thehoff | 1281 comments
An Asterisk Magazine forecast essay by Greg Justice on how long until the 100+ million Americans who could benefit from GLP-1 drugs like Ozempic can access them.